✦ LIBER ✦

The Lesch-Nyhan syndrome: clinical, molecular and genetic aspects

✍ Scribed by J. Timothy Stout; C. Thomas Caskey

Book ID: 113288611
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 530 KB
Volume: 4
Category: Article
ISSN: 0168-9525
DOI: 10.1016/0168-9525(88)90024-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lesch-Nyhan syndrome: An overview of pha

Lesch-Nyhan syndrome: An overview of pharmacologic and molecular genetic aspects

✍ Johnson, Lynelle T. ;Patel, Pragna I. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 1019 KB

The enzyme hypoxanthine phosphoribosyltransferase (HPRT), expressed at low levels in non-neuronal tissues and higher levels in the brain, catalyzes the cellular salvage of the purine bases hypoxanthine and guanine. A complete deficiency of HPRT results in Lesch-Nyhan syndrome (LNS). LNS is character

The molecular biology of Lesch-Nyhan syn

The molecular biology of Lesch-Nyhan syndrome

✍ S.A. Stein; M.R. Morrison 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 302 KB

THE LESCH-NYHAN SYNDROME

✍ Kenneth S. Holt 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB

THE LESCH-NYHAN SYNDROME

✍ William L. Nyhan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB

HPRT and the Lesch—Nyhan syndrome

✍ Pragna I. Patel; C. Thomas Caskey 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB

De$ciency of the enzyme hypoxanthineguanine phosphoribosyltransferase (HPRT) in humans leads to the neurological disorder, Lesch-Nyhan syndrome. HPRTcDNA sequences have been used to demonstrate a heterogeneous group of mutations causing this disorder, one of which is clearly a new mutation. HPRT ex

Screening for molecular pathologies in L

Screening for molecular pathologies in Lesch-Nyhan syndrome

✍ Marie Boyd; W. George Lanyon; J. Michael Connor 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

## Communicated by Uta Fruncke Heteroduplex detection by hydrolink gel electrophoresis was performed to screen for small mutations in 12 Lesch-Nyhan syndrome families with characterised molecular pathology which included nine point mutations, two small deletions, and a 1-bp insertion. This modifie